Key Insights

Highlights

Treatment Research

2 treatments under study, led by Goalai

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07232056Not ApplicableNot Yet RecruitingPrimary

Geriatric Oncology Assessment and Coping Skills Training for Older Women on Aromatase Inhibitor Therapy

Showing all 1 trials

Research Network

Common Treatments

  • Goalai1
  • Cstai1

Active Sponsors

  • Duke University1
  • National Cancer Institute (NCI)1

Top Investigators

Activity Timeline